STRATIFYER Molecular Pathology GmbH – Trademark Portfolio

Entity Type: 99

STRATIFYER Molecular Pathology GmbH holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. The owner is based in COLOGNE.

Werthmannstr. 1

COLOGNE 50935 , DE

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

STRATIFYER Molecular Pathology GmbH's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

16
Paper Goods (1 filing)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

Frequently Asked Questions

How many trademarks does STRATIFYER Molecular Pathology GmbH have?

STRATIFYER Molecular Pathology GmbH has 3 U.S. trademarks filed with the USPTO.

What trademark classes does STRATIFYER Molecular Pathology GmbH file in?

STRATIFYER Molecular Pathology GmbH files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is STRATIFYER Molecular Pathology GmbH's trademark registration success rate?

STRATIFYER Molecular Pathology GmbH has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.